Immediate Impact

1 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes
2024 Standout
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
7 intermediate papers

Works of Haluk Onat being referenced

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial
2007
Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients
2005
and 1 more

Author Peers

Author Last Decade Papers Cites
Haluk Onat 417 731 79 470 30 1.2k
I. Benjamin Paz 599 658 109 383 45 1.4k
Mohamed S. Razack 426 596 69 562 42 1.1k
Richard W. Nason 453 888 73 701 40 1.4k
Gioacchino Giugliano 319 597 53 517 52 1.1k
J Vallicioni 404 645 83 573 48 1.2k
Yasser Khafaga 431 301 332 251 49 1.2k
Sanjay Talole 449 408 50 167 54 995
Cyrus A. Kotwall 588 628 92 222 39 1.2k
José Magrin 358 739 28 640 32 1.1k
Paul Y. Holoye 603 470 93 178 46 1.4k

All Works

Loading papers...

Rankless by CCL
2026